LineaRx, EvviVax Publish Additional Positive Animal Proof-of-Concept Data

July 25, 2022

Read More

Applied DNA Biotherapeutics Subsidiary LineaRx to Present Data Showcasing Advantages of its Enzymatically Produced LinearDNA as Substitute for Plasmid DNA in IVT mRNA Production

July 22, 2022

Read More

LinearDNA: Alternative to Plasmid DNA for Therapeutic Applications

June 29, 2022

Read More

U.S. Gov’t Guidance Permits DNA Traceability, Isotopic Testing as Evidence

June 21, 2022

Read More

Positive Preclinical Data for LinearDNA™ as Novel Cancer Vaccine Strategy

June 7, 2022

Read More

Applied DNA Reports Second Quarter Fiscal 2022 Financial Results

May 12, 2022

Read More

APDN Schedules FY’22 Q2 Results Conference Call & Webcast

May 9, 2022

Read More

APDN Awarded NYC-based ‘Return-to-Office’ Health Services Contract

April 6, 2022

Read More

Applied DNA to Participate in 2022 Maxim Virtual Growth Conference

March 23, 2022

Read More